Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
United States Department of Veterans Affairs | 11 | 2015 | 928 | 0.920 |
Why?
|
Fee-for-Service Plans | 8 | 2014 | 700 | 0.500 |
Why?
|
Medicare | 25 | 2014 | 6770 | 0.500 |
Why?
|
Healthcare Disparities | 5 | 2014 | 3358 | 0.470 |
Why?
|
Quality of Health Care | 15 | 2015 | 4330 | 0.460 |
Why?
|
Hospitals, Veterans | 7 | 2015 | 395 | 0.420 |
Why?
|
SEER Program | 18 | 2014 | 1450 | 0.420 |
Why?
|
Colorectal Neoplasms | 13 | 2015 | 6935 | 0.400 |
Why?
|
Skin Diseases, Infectious | 1 | 2012 | 76 | 0.390 |
Why?
|
Soft Tissue Infections | 1 | 2012 | 168 | 0.350 |
Why?
|
Reimbursement, Incentive | 3 | 2012 | 543 | 0.340 |
Why?
|
Lung Neoplasms | 19 | 2015 | 13382 | 0.340 |
Why?
|
Veterans | 3 | 2012 | 2649 | 0.330 |
Why?
|
Quality Indicators, Health Care | 13 | 2015 | 1792 | 0.320 |
Why?
|
Guideline Adherence | 8 | 2012 | 2220 | 0.300 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 8 | 2015 | 5315 | 0.300 |
Why?
|
Hospital Administration | 1 | 2012 | 353 | 0.300 |
Why?
|
Pneumonectomy | 2 | 2011 | 1119 | 0.290 |
Why?
|
Minority Groups | 3 | 2012 | 1203 | 0.290 |
Why?
|
Propensity Score | 3 | 2013 | 1913 | 0.280 |
Why?
|
Myocardial Infarction | 17 | 2010 | 11461 | 0.270 |
Why?
|
Coronary Angiography | 9 | 2004 | 4471 | 0.270 |
Why?
|
Bayes Theorem | 3 | 2014 | 2330 | 0.260 |
Why?
|
Rectal Neoplasms | 2 | 2012 | 1157 | 0.260 |
Why?
|
Cluster Analysis | 1 | 2013 | 2707 | 0.260 |
Why?
|
United States | 53 | 2015 | 72335 | 0.250 |
Why?
|
Models, Statistical | 7 | 2014 | 5079 | 0.230 |
Why?
|
Health Services Misuse | 4 | 2014 | 244 | 0.220 |
Why?
|
Neoplasms | 16 | 2015 | 22173 | 0.220 |
Why?
|
Health Expenditures | 4 | 2013 | 2366 | 0.220 |
Why?
|
Antimanic Agents | 1 | 2007 | 520 | 0.220 |
Why?
|
Colonic Neoplasms | 3 | 2011 | 2538 | 0.210 |
Why?
|
Small-Area Analysis | 3 | 2014 | 55 | 0.210 |
Why?
|
Managed Care Programs | 6 | 2007 | 940 | 0.210 |
Why?
|
Anti-Retroviral Agents | 1 | 2012 | 1784 | 0.200 |
Why?
|
Breast Neoplasms | 15 | 2014 | 21017 | 0.200 |
Why?
|
Aged, 80 and over | 36 | 2015 | 58986 | 0.190 |
Why?
|
Hospice Care | 6 | 2011 | 678 | 0.180 |
Why?
|
Cost of Illness | 2 | 2008 | 1936 | 0.170 |
Why?
|
Aged | 59 | 2015 | 169310 | 0.170 |
Why?
|
Patient Admission | 1 | 2007 | 1367 | 0.170 |
Why?
|
Quality Assurance, Health Care | 5 | 2008 | 2169 | 0.170 |
Why?
|
Health Care Costs | 3 | 2012 | 3242 | 0.160 |
Why?
|
Hospitals | 5 | 2012 | 3882 | 0.160 |
Why?
|
Terminal Care | 5 | 2010 | 1761 | 0.160 |
Why?
|
Practice Guidelines as Topic | 9 | 2012 | 7391 | 0.160 |
Why?
|
Sterol O-Acyltransferase | 1 | 1998 | 28 | 0.150 |
Why?
|
Physician-Patient Relations | 6 | 2015 | 3249 | 0.150 |
Why?
|
Psychotherapy | 1 | 2007 | 1647 | 0.150 |
Why?
|
Medicare Part C | 2 | 2013 | 334 | 0.150 |
Why?
|
Patient Preference | 2 | 2015 | 924 | 0.140 |
Why?
|
Cost Sharing | 2 | 2013 | 409 | 0.140 |
Why?
|
Apolipoprotein A-I | 1 | 1998 | 299 | 0.140 |
Why?
|
Health Maintenance Organizations | 2 | 2012 | 659 | 0.120 |
Why?
|
Logistic Models | 20 | 2015 | 13255 | 0.120 |
Why?
|
Medicaid | 2 | 2007 | 2818 | 0.120 |
Why?
|
Competitive Bidding | 1 | 2013 | 16 | 0.110 |
Why?
|
Male | 56 | 2015 | 360842 | 0.110 |
Why?
|
Ambulatory Care | 5 | 2007 | 2775 | 0.110 |
Why?
|
Survivors | 4 | 2009 | 2371 | 0.110 |
Why?
|
Hospices | 2 | 2014 | 245 | 0.110 |
Why?
|
Age Factors | 10 | 2014 | 18398 | 0.110 |
Why?
|
Humans | 86 | 2015 | 761572 | 0.110 |
Why?
|
Female | 61 | 2015 | 392686 | 0.110 |
Why?
|
Patient Satisfaction | 4 | 2015 | 3461 | 0.110 |
Why?
|
Military Personnel | 2 | 2012 | 1246 | 0.110 |
Why?
|
Patient Participation | 4 | 2015 | 1445 | 0.100 |
Why?
|
Patient Selection | 5 | 2009 | 4244 | 0.100 |
Why?
|
Patient Care Team | 2 | 2015 | 2521 | 0.100 |
Why?
|
AIDS-Associated Nephropathy | 1 | 2012 | 34 | 0.100 |
Why?
|
Contracts | 1 | 2012 | 60 | 0.100 |
Why?
|
Residence Characteristics | 4 | 2014 | 2094 | 0.100 |
Why?
|
Monte Carlo Method | 2 | 2013 | 1258 | 0.100 |
Why?
|
Competitive Behavior | 1 | 2012 | 78 | 0.100 |
Why?
|
Terminally Ill | 1 | 2014 | 240 | 0.100 |
Why?
|
Decision Making | 6 | 2015 | 3929 | 0.100 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2011 | 34 | 0.090 |
Why?
|
Early Detection of Cancer | 3 | 2015 | 3201 | 0.090 |
Why?
|
Urban Population | 2 | 2014 | 2036 | 0.090 |
Why?
|
Bipolar Disorder | 2 | 2013 | 5092 | 0.090 |
Why?
|
Survival Analysis | 5 | 2015 | 10090 | 0.090 |
Why?
|
Survival | 1 | 2011 | 161 | 0.090 |
Why?
|
Interdisciplinary Communication | 2 | 2015 | 931 | 0.090 |
Why?
|
Budgets | 1 | 2012 | 230 | 0.090 |
Why?
|
Comorbidity | 7 | 2012 | 10508 | 0.090 |
Why?
|
Longitudinal Studies | 6 | 2012 | 14607 | 0.090 |
Why?
|
Data Collection | 7 | 2009 | 3322 | 0.090 |
Why?
|
Medical Records | 2 | 2014 | 1408 | 0.090 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2015 | 423 | 0.090 |
Why?
|
Benchmarking | 2 | 2013 | 1045 | 0.090 |
Why?
|
Treatment Refusal | 2 | 2011 | 429 | 0.090 |
Why?
|
Insurance Coverage | 2 | 2013 | 1940 | 0.090 |
Why?
|
Truth Disclosure | 1 | 2014 | 434 | 0.090 |
Why?
|
Socioeconomic Factors | 5 | 2014 | 7827 | 0.090 |
Why?
|
Health Services Research | 6 | 2013 | 1812 | 0.080 |
Why?
|
Carcinoma, Small Cell | 1 | 2012 | 420 | 0.080 |
Why?
|
DNA, Neoplasm | 1 | 2015 | 1745 | 0.080 |
Why?
|
HIV Infections | 3 | 2012 | 17352 | 0.080 |
Why?
|
Health Care Surveys | 6 | 2015 | 2426 | 0.080 |
Why?
|
Choice Behavior | 1 | 2015 | 824 | 0.080 |
Why?
|
Middle Aged | 34 | 2015 | 220920 | 0.080 |
Why?
|
Cost Savings | 2 | 2012 | 913 | 0.080 |
Why?
|
Analysis of Variance | 2 | 2012 | 6228 | 0.080 |
Why?
|
Models, Organizational | 1 | 2012 | 546 | 0.080 |
Why?
|
Medicare Part D | 1 | 2013 | 355 | 0.080 |
Why?
|
Commerce | 1 | 2013 | 606 | 0.080 |
Why?
|
Program Evaluation | 3 | 2013 | 2495 | 0.080 |
Why?
|
Primary Health Care | 6 | 2007 | 4686 | 0.070 |
Why?
|
Preferred Provider Organizations | 1 | 2007 | 38 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1626 | 0.070 |
Why?
|
Health Services Accessibility | 4 | 2014 | 5440 | 0.070 |
Why?
|
Formularies as Topic | 1 | 2007 | 94 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2011 | 3514 | 0.070 |
Why?
|
Referral and Consultation | 5 | 2007 | 3600 | 0.070 |
Why?
|
Patient Compliance | 2 | 2007 | 2690 | 0.070 |
Why?
|
Social Security | 1 | 2007 | 101 | 0.070 |
Why?
|
Family Practice | 3 | 2005 | 512 | 0.070 |
Why?
|
HIV Seropositivity | 1 | 2012 | 960 | 0.070 |
Why?
|
Prostatic Neoplasms | 6 | 2015 | 11122 | 0.070 |
Why?
|
Data Interpretation, Statistical | 2 | 2014 | 2691 | 0.070 |
Why?
|
Odds Ratio | 4 | 2015 | 9646 | 0.070 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2011 | 1784 | 0.070 |
Why?
|
Registries | 5 | 2013 | 8224 | 0.060 |
Why?
|
Cohort Studies | 14 | 2013 | 41493 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1403 | 0.060 |
Why?
|
Medical Oncology | 4 | 2007 | 2321 | 0.060 |
Why?
|
Regression Analysis | 6 | 2010 | 6344 | 0.060 |
Why?
|
Delphi Technique | 2 | 1999 | 846 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2015 | 4016 | 0.060 |
Why?
|
Income | 3 | 2009 | 1877 | 0.060 |
Why?
|
Health Facilities | 1 | 2009 | 580 | 0.060 |
Why?
|
Education, Continuing | 1 | 2005 | 114 | 0.060 |
Why?
|
Cardiology | 3 | 2006 | 1656 | 0.060 |
Why?
|
Neoplasm Staging | 8 | 2015 | 11121 | 0.060 |
Why?
|
Computer Simulation | 2 | 2013 | 6241 | 0.060 |
Why?
|
Patient Care | 1 | 2009 | 622 | 0.060 |
Why?
|
Family | 1 | 2015 | 3194 | 0.060 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12463 | 0.060 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2009 | 1148 | 0.060 |
Why?
|
Prostatectomy | 1 | 2012 | 1824 | 0.060 |
Why?
|
Unnecessary Procedures | 1 | 2007 | 415 | 0.050 |
Why?
|
Communication | 3 | 2015 | 3873 | 0.050 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2011 | 942 | 0.050 |
Why?
|
Employment | 1 | 2009 | 1118 | 0.050 |
Why?
|
Radiation Oncology | 1 | 2009 | 563 | 0.050 |
Why?
|
Population Surveillance | 3 | 2013 | 2598 | 0.050 |
Why?
|
Practice Management, Medical | 1 | 2004 | 191 | 0.050 |
Why?
|
Adult | 21 | 2015 | 221203 | 0.050 |
Why?
|
Minnesota | 4 | 2004 | 338 | 0.050 |
Why?
|
Multivariate Analysis | 7 | 2015 | 12059 | 0.050 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2012 | 1188 | 0.050 |
Why?
|
Trust | 1 | 2007 | 530 | 0.050 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2012 | 1405 | 0.050 |
Why?
|
Genetic Testing | 1 | 2015 | 3537 | 0.050 |
Why?
|
Gatekeeping | 1 | 2001 | 49 | 0.050 |
Why?
|
Neoplasm Metastasis | 4 | 2014 | 4915 | 0.050 |
Why?
|
Hospital Costs | 1 | 2007 | 947 | 0.050 |
Why?
|
Diabetes Mellitus | 3 | 2004 | 5841 | 0.050 |
Why?
|
Mastectomy, Segmental | 2 | 2010 | 955 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2319 | 0.050 |
Why?
|
Insurance, Health | 2 | 2013 | 2498 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6484 | 0.050 |
Why?
|
Diagnostic Tests, Routine | 1 | 2007 | 787 | 0.050 |
Why?
|
Survival Rate | 2 | 2012 | 12725 | 0.050 |
Why?
|
Human Experimentation | 1 | 2001 | 123 | 0.050 |
Why?
|
Aftercare | 1 | 2007 | 914 | 0.050 |
Why?
|
Androgen Antagonists | 1 | 2009 | 1410 | 0.050 |
Why?
|
Delivery of Health Care | 2 | 2010 | 5336 | 0.050 |
Why?
|
Tobacco Industry | 1 | 2002 | 136 | 0.050 |
Why?
|
Treatment Outcome | 6 | 2015 | 64684 | 0.040 |
Why?
|
Utilization Review | 2 | 2001 | 382 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3530 | 0.040 |
Why?
|
Birth Rate | 1 | 2001 | 168 | 0.040 |
Why?
|
Antipsychotic Agents | 1 | 2013 | 3067 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2015 | 5492 | 0.040 |
Why?
|
Medicine | 3 | 2010 | 942 | 0.040 |
Why?
|
Self Care | 1 | 2004 | 796 | 0.040 |
Why?
|
Prospective Studies | 6 | 2015 | 54426 | 0.040 |
Why?
|
Testosterone | 1 | 2009 | 2472 | 0.040 |
Why?
|
Health Services | 1 | 2004 | 752 | 0.040 |
Why?
|
Cholesterol Esters | 1 | 1998 | 74 | 0.040 |
Why?
|
Normal Distribution | 1 | 1999 | 272 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2012 | 2243 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 8002 | 0.040 |
Why?
|
Anticholesteremic Agents | 2 | 2002 | 966 | 0.040 |
Why?
|
Circular Dichroism | 1 | 1998 | 344 | 0.040 |
Why?
|
Mammography | 2 | 2006 | 2430 | 0.040 |
Why?
|
Specialization | 2 | 2001 | 778 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2010 | 3204 | 0.040 |
Why?
|
Tamoxifen | 1 | 2002 | 965 | 0.040 |
Why?
|
Inpatients | 1 | 2009 | 2548 | 0.040 |
Why?
|
Cost Control | 2 | 2012 | 628 | 0.040 |
Why?
|
Hypolipidemic Agents | 1 | 2002 | 609 | 0.040 |
Why?
|
Epitope Mapping | 1 | 1998 | 298 | 0.040 |
Why?
|
Antineoplastic Agents | 3 | 2010 | 13642 | 0.040 |
Why?
|
Massachusetts | 6 | 2012 | 8830 | 0.040 |
Why?
|
Incidence | 2 | 2012 | 21355 | 0.040 |
Why?
|
Quality Improvement | 1 | 2012 | 3801 | 0.030 |
Why?
|
Cholesterol | 2 | 2004 | 2904 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2005 | 1897 | 0.030 |
Why?
|
Solubility | 1 | 1998 | 1091 | 0.030 |
Why?
|
Expert Testimony | 1 | 1999 | 364 | 0.030 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1998 | 783 | 0.030 |
Why?
|
Retrospective Studies | 12 | 2015 | 80646 | 0.030 |
Why?
|
Electrocardiography | 2 | 2006 | 6377 | 0.030 |
Why?
|
Databases, Factual | 3 | 2011 | 7967 | 0.030 |
Why?
|
Markov Chains | 1 | 1999 | 966 | 0.030 |
Why?
|
Interviews as Topic | 3 | 2013 | 2696 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 1998 | 1229 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2007 | 2897 | 0.030 |
Why?
|
California | 2 | 2014 | 1430 | 0.030 |
Why?
|
Physician's Role | 1 | 2001 | 917 | 0.030 |
Why?
|
Iowa | 1 | 2014 | 104 | 0.030 |
Why?
|
Phospholipids | 1 | 1998 | 786 | 0.030 |
Why?
|
Alabama | 1 | 2014 | 108 | 0.030 |
Why?
|
Risk Factors | 5 | 2014 | 74213 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5146 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2002 | 1520 | 0.030 |
Why?
|
Smoking | 3 | 2010 | 9053 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 1998 | 676 | 0.030 |
Why?
|
North Carolina | 1 | 2014 | 325 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 14666 | 0.030 |
Why?
|
Attitude of Health Personnel | 2 | 2015 | 3889 | 0.030 |
Why?
|
Emergency Services, Psychiatric | 1 | 2013 | 67 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2015 | 39107 | 0.030 |
Why?
|
Physicians | 2 | 2008 | 4591 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2013 | 2927 | 0.030 |
Why?
|
Adaptation, Psychological | 1 | 2003 | 2629 | 0.030 |
Why?
|
Veterans Health | 1 | 2014 | 215 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 1998 | 3076 | 0.030 |
Why?
|
Health Status | 1 | 2005 | 4077 | 0.030 |
Why?
|
Anxiety | 1 | 2007 | 4573 | 0.030 |
Why?
|
Enzyme Activation | 1 | 1998 | 3597 | 0.020 |
Why?
|
Empirical Research | 1 | 2012 | 120 | 0.020 |
Why?
|
Costs and Cost Analysis | 2 | 2012 | 1668 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2015 | 999 | 0.020 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 1 | 2012 | 92 | 0.020 |
Why?
|
Time Factors | 5 | 2015 | 39970 | 0.020 |
Why?
|
Organizational Case Studies | 1 | 2012 | 301 | 0.020 |
Why?
|
Medical Record Linkage | 1 | 2012 | 285 | 0.020 |
Why?
|
Mental Health | 1 | 2005 | 3250 | 0.020 |
Why?
|
Young Adult | 6 | 2015 | 59255 | 0.020 |
Why?
|
Rural Population | 1 | 2001 | 2285 | 0.020 |
Why?
|
Office Visits | 2 | 2007 | 595 | 0.020 |
Why?
|
Mutation | 1 | 2015 | 30054 | 0.020 |
Why?
|
Drug Utilization | 2 | 2007 | 1188 | 0.020 |
Why?
|
Protein Conformation | 1 | 1998 | 3968 | 0.020 |
Why?
|
Prognosis | 4 | 2015 | 29629 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2002 | 2057 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2015 | 1125 | 0.020 |
Why?
|
Awareness | 1 | 2014 | 648 | 0.020 |
Why?
|
Viral Load | 2 | 2012 | 3332 | 0.020 |
Why?
|
Comprehension | 1 | 2015 | 621 | 0.020 |
Why?
|
Clinical Competence | 1 | 2005 | 4793 | 0.020 |
Why?
|
Intensive Care Units | 3 | 2010 | 3744 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2510 | 0.020 |
Why?
|
Perception | 1 | 2015 | 1197 | 0.020 |
Why?
|
Health Personnel | 1 | 2002 | 3335 | 0.020 |
Why?
|
Models, Economic | 1 | 2012 | 716 | 0.020 |
Why?
|
Hospitalization | 4 | 2013 | 10721 | 0.020 |
Why?
|
Private Sector | 1 | 2011 | 398 | 0.020 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2009 | 297 | 0.020 |
Why?
|
Mastectomy | 2 | 2010 | 1822 | 0.020 |
Why?
|
Pneumonia | 2 | 2010 | 2143 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1505 | 0.020 |
Why?
|
Biostatistics | 1 | 2009 | 164 | 0.020 |
Why?
|
Depression | 1 | 2007 | 8124 | 0.020 |
Why?
|
Incidental Findings | 1 | 2012 | 697 | 0.020 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2006 | 1725 | 0.020 |
Why?
|
Statistics, Nonparametric | 2 | 2004 | 2850 | 0.020 |
Why?
|
Financing, Personal | 1 | 2009 | 309 | 0.020 |
Why?
|
Demography | 2 | 2002 | 1648 | 0.020 |
Why?
|
Professional Practice | 1 | 2009 | 313 | 0.020 |
Why?
|
Program Development | 1 | 2013 | 1297 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 2571 | 0.020 |
Why?
|
Protein Binding | 1 | 1998 | 9353 | 0.020 |
Why?
|
Community Health Services | 1 | 2009 | 656 | 0.010 |
Why?
|
Algorithms | 3 | 2014 | 14032 | 0.010 |
Why?
|
Health Care Reform | 1 | 2013 | 1247 | 0.010 |
Why?
|
Age of Onset | 1 | 2011 | 3306 | 0.010 |
Why?
|
Sex Factors | 3 | 2002 | 10553 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 1999 | 20099 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2012 | 2177 | 0.010 |
Why?
|
Thoracic Surgery | 1 | 2010 | 722 | 0.010 |
Why?
|
Internal Medicine | 2 | 2002 | 1051 | 0.010 |
Why?
|
Coronary Artery Bypass | 2 | 2002 | 2188 | 0.010 |
Why?
|
Radiotherapy | 1 | 2010 | 1499 | 0.010 |
Why?
|
Efficiency, Organizational | 1 | 2007 | 695 | 0.010 |
Why?
|
Health Care Sector | 1 | 2005 | 195 | 0.010 |
Why?
|
Insurance Claim Review | 1 | 2007 | 741 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 11742 | 0.010 |
Why?
|
Long-Term Care | 1 | 2007 | 633 | 0.010 |
Why?
|
Quality of Life | 1 | 2003 | 13367 | 0.010 |
Why?
|
Ethics | 1 | 2001 | 94 | 0.010 |
Why?
|
Administration, Oral | 1 | 2009 | 4021 | 0.010 |
Why?
|
Role | 1 | 2002 | 176 | 0.010 |
Why?
|
Medication Adherence | 1 | 2013 | 2176 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11076 | 0.010 |
Why?
|
Risk Assessment | 2 | 2002 | 23996 | 0.010 |
Why?
|
Axilla | 1 | 2003 | 624 | 0.010 |
Why?
|
American Heart Association | 1 | 2006 | 1039 | 0.010 |
Why?
|
Matched-Pair Analysis | 1 | 2001 | 284 | 0.010 |
Why?
|
Insurance Claim Reporting | 1 | 2001 | 166 | 0.010 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2004 | 662 | 0.010 |
Why?
|
Cardiology Service, Hospital | 1 | 2002 | 239 | 0.010 |
Why?
|
Ethics Committees, Research | 1 | 2001 | 196 | 0.010 |
Why?
|
Florida | 1 | 2001 | 431 | 0.010 |
Why?
|
Taxes | 1 | 2002 | 221 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2759 | 0.010 |
Why?
|
State Government | 1 | 2002 | 384 | 0.010 |
Why?
|
Research Design | 2 | 2005 | 6180 | 0.010 |
Why?
|
Mass Screening | 2 | 2005 | 5428 | 0.010 |
Why?
|
General Surgery | 1 | 2010 | 1692 | 0.010 |
Why?
|
New England | 1 | 2001 | 1054 | 0.010 |
Why?
|
Adolescent | 3 | 2012 | 88324 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 2001 | 694 | 0.010 |
Why?
|
Emergency Service, Hospital | 2 | 2010 | 7879 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2007 | 1998 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 2003 | 1271 | 0.010 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2005 | 926 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 8528 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 3688 | 0.010 |
Why?
|
Boston | 1 | 2010 | 9326 | 0.010 |
Why?
|
Primary Prevention | 1 | 2004 | 1186 | 0.010 |
Why?
|
Thrombolytic Therapy | 1 | 2006 | 2064 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2012 | 4527 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2001 | 1241 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2002 | 1475 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13510 | 0.010 |
Why?
|
Software | 1 | 2009 | 4434 | 0.010 |
Why?
|
Life Expectancy | 1 | 2002 | 1242 | 0.010 |
Why?
|
HIV-1 | 1 | 2012 | 6863 | 0.010 |
Why?
|
Radiography | 1 | 2006 | 6965 | 0.010 |
Why?
|
Schizophrenia | 1 | 2013 | 6937 | 0.010 |
Why?
|
Health Behavior | 1 | 2005 | 2644 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2002 | 2208 | 0.010 |
Why?
|
Educational Status | 1 | 2001 | 2522 | 0.010 |
Why?
|
Forecasting | 1 | 2002 | 2928 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15843 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2001 | 1670 | 0.010 |
Why?
|
Chronic Disease | 1 | 2005 | 9319 | 0.010 |
Why?
|
Mental Health Services | 1 | 2002 | 1730 | 0.010 |
Why?
|
Aspirin | 1 | 2001 | 3133 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2005 | 22176 | 0.000 |
Why?
|
Cardiovascular Diseases | 2 | 2002 | 15501 | 0.000 |
Why?
|
Heart Failure | 1 | 2010 | 11670 | 0.000 |
Why?
|
Aging | 1 | 2003 | 8711 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2003 | 26127 | 0.000 |
Why?
|